Akiko Fujii

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non–small cell lung cancer harboring <i>EGFR</i> mutations

Kentaro Tanaka, Kaname Nosaki, Kohei Otsubo et al. · Oncotarget · 2017 · 77 citations · Full text

Medicine, Oncology, Pharmacology +13

Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.

K Yamagami, Akiko Fujii, Makoto Arita et al. · PubMed · 1991 · 60 citations

Medicine, Oncology, Pharmacology +10

Sensitivity and kinase activity of epidermal growth factor receptor (<scp>EGFR</scp>) exon 19 and others to <scp>EGFR</scp>‐tyrosine kinase inhibitors

Kazuto Furuyama, Taishi Harada, Eiji Iwama et al. · Cancer Science · 2013 · 50 citations · Full text

Medicine, Oncology, Pharmacology +16

Nicotine induces resistance to erlotinib via cross-talk between α 1 nAChR and EGFR in the non-small cell lung cancer xenograft model

Heyan Li, Shuo Wang, Koichi Takayama et al. · Lung Cancer · 2015 · 36 citations · Full text

Medicine, Oncology, Pharmacology +12

Longitudinal monitoring of somatic genetic alterations in circulating cell‐free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors

Eiji Iwama, Kazuko Sakai, Noriko Hidaka et al. · Cancer · 2019 · 29 citations

Medicine, Molecular Genetics, Oncology +17